Clinical Trial Update: Natural Soybean-derived Femarelle ®for Patients With Non Alcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial of natural soybean-derived Femarelle for non-alcoholic fatty liver disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Femarelle

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Nash | Phase 4 | Status: WITHDRAWN